Home | CIMAvax-EGF®-post-COVID19 convalescent with respiratory disorders-adults-Phase II (CORVAXCIM)

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials CIMAvax-EGF®-post-COVID19 convalescent with respiratory disorders-adults-Phase II (CORVAXCIM) has 5 revisions.
RevisionStatus
Saved 08/01/2026 - 6:07am by Gladys
in draft/pending publication
Saved 19/07/2023 - 2:27pm by Gladys
current revision (published)
Saved 06/12/2021 - 7:25pm by CIM
archived
Saved 18/06/2021 - 1:19pm by Gladys
archived
Saved 18/06/2021 - 11:53am by Gladys
archived